Facebook
Twitter
Telegram
Report an ErrorZIOPHARM Oncology, Inc. Financial Statements 2011-2024 | ZIOP
Annual Financial Statements ZIOPHARM Oncology, Inc.
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
790 M | 685 M | 301 M | 575 M | 756 M | 623 M | 905 M | 376 M | 314 M | 358 M |
Shares |
213 M | 168 M | 144 M | 137 M | 130 M | 125 M | 101 M | 85.9 M | 78.5 M | 66 M |
Net Income |
-80 M | -118 M | -53.1 M | -54.3 M | -165 M | -120 M | -31.8 M | -57.1 M | -96.1 M | -63.8 M |
Revenue |
- | - | 146 K | 6.39 M | 6.86 M | 4.33 M | 1.37 M | 800 K | 800 K | 667 K |
EBITDA |
-79.2 M | -57.2 M | -53.3 M | -53.1 M | -165 M | -120 M | -43 M | -57 M | -102 M | -71.1 M |
Operating Expenses |
80.4 M | 57.9 M | 54.1 M | 59.9 M | 172 M | 124 M | 44.9 M | 58.5 M | 103 M | 72.1 M |
General and Administrative Expenses |
27.7 M | 19.5 M | 19.9 M | 14.8 M | 14.4 M | 17.6 M | 12.2 M | 15.7 M | 19.5 M | 15 M |
All numbers in USD currency